Cartesian Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $125.1M | $212.6M | $76.9M | $106.4M | $114.1M | $138.7M | $89.9M | $37.4M |
| Accounts Receivable | $1.1M | $872.0K | $5.9M | $6.6M | $9.9M | $7.2M | $5.0M | $0 |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $129.3M | $216.6M | $90.7M | $148.1M | $144.4M | $151.3M | $96.7M | $42.1M |
| Property, Plant & Equipment | $12.2M | $9.9M | $2.1M | $2.8M | $2.1M | $1.4M | $1.2M | $2.1M |
| Goodwill | $48.2M | $48.2M | $48.2M | $0 | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $296.4M | $435.0M | $305.1M | $165.9M | $159.9M | $165.4M | $99.6M | $44.5M |
| Liabilities | ||||||||
| Accounts Payable | $1.3M | $288.0K | $3.2M | $316.0K | $224.0K | $443.0K | $500.0K | $1.1M |
| Total Current Liabilities | $14.9M | $23.0M | $68.2M | $25.1M | $72.3M | $81.5M | $34.9M | $35.1M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $422.7M | $441.8M | $444.7M | $72.1M | $137.4M | $183.4M | $91.2M | $49.9M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-822.4M | $-692.1M | $-614.6M | $-394.9M | $-430.3M | $-404.6M | $-335.8M | $-280.4M |
| Total Stockholders' Equity | $-126.2M | $-6.8M | $-440.2M | $93.8M | $22.5M | $-18.0M | $8.4M | $-5.4M |